Skip to main
TB-500 Clinic

An editorial dark-folio reading of the TB-500 literature — what the thymosin beta-4 fragment is actually studied for, where the human data stop, and how compounded and regulated access really stands.

Section 04 — what study amounts mean

What TB-500 dosage research leaves unknown for your care

An injury that won't heal can send you looking for a treatment amount. Most studies tested another substance, often in animals. The study amounts leave the small protein part's effects unproved.

What TB-500 dosage numbers measured, and in whom

When your injury lingers, a printed amount may look like a clear answer. But TB-500 dosage figures mostly belong to whole thymosin beta-4. Tests of another substance can't give you an amount for the seven-part piece. Who received treatment, how treatment entered the body, and what was tested all matter.

Rodents with brain or heart damage received thymosin beta-4 at about 6–12 milligrams per kilogram the rodents weighed. The animal's weight determines how much such an amount means. In rats after stroke, researchers used thymosin beta-4 at 2, 12, and 18 milligrams per kilogram, with shots into the belly [4]. A calculation suggested a best amount, without testing that amount in people. Mice with an inherited muscle disease received 150 micrograms into the belly twice a week over six months [5]. A microgram is a millionth of a gram. Those mouse amounts don't guide your injury treatment.

The human amounts tested early safety, rather than relief from an illness.

Phase 1 means an early study checking for harm. The human test gave whole thymosin beta-4 into a vein [6]. People received 42, 140, 420, or 1260 milligrams once, followed by daily treatment for 14 days. Researchers checked unwanted effects and how the body cleared the protein. Those figures don't tell you what treats a wound or sore joint. A safety study and a healing study ask different questions.

Cells in a dish can respond to far smaller amounts.

Dish tests found more skin-cell movement with about 10 picograms of protein [3][5]. A picogram equals one trillionth of a gram. Tiny amounts also stimulated cells that can grow hair. A dish test and a human vein treatment at 1260 milligrams don't measure the same thing. Neither provides a tested amount for TB-500 in your care.

Why a shot, a vein treatment, and eye drops differ

Repair tests usually gave rodents shots into the belly [4][5]. Human Phase 1 testing, an early check for harm, gave whole thymosin beta-4 into a vein [6]. Vein treatment was also used in some heart research. Eye research applied the protein directly to the eye. That included RGN-259, eye drops containing whole thymosin beta-4 [7][8]. How a substance enters your body may affect your response.

People trying the substance themselves describe shots into muscle and shots beneath the skin. These accounts come from research-use groups, rather than controlled human treatment tests. FDA has raised concerns about unwanted immune responses depending on how the substance enters the body. Your immune system protects you, but can react to a substance in harmful ways. The whole-protein human tests don't settle that risk for shots of the short piece.

The label on a research product doesn't assure its contents or safety.

TB-500 is supplied as dried powder, mixed with sterile water and kept cold. Some mixing water also slows bacterial growth. Some chemical reactions can break proteins apart; the short part withstands that damage better than the full protein. That doesn't show a safer shot or how long a bottle keeps. Repeated freezing and thawing can damage the short part, and the body can break the short part down too. With little oversight of research products, the stated contents and purity aren't assured. Wrong contents make your risk and any reported result harder to judge.

Why a shot, a vein treatment, and eye drops differ

Why taking more at first has no human proof

People trying TB-500 themselves sometimes describe starting with more, then using less. Those plans come from research-use groups outside controlled studies. No published human comparison study has shown the plans work or are safe [5]. Repeated personal accounts can't supply that missing proof for your care.

Rats after stroke improved with thymosin beta-4 at 2 and 12 milligrams per kilogram the rats weighed. The protein went into the belly. The rats receiving 18 milligrams per kilogram didn't clearly improve [4]. A calculation suggested a best amount, without testing that amount in a person. The largest amount failed to help in this animal test. That finding questions the claim that starting with more brings better repair.

The rat results give you no proved amount for the short piece.

The rats received the protein in its full form, rather than the separated small part. The short piece may travel through the body or act differently. A shot into the belly is also different from a shot under skin. Your body isn't a rat's body, and the animal results don't settle those differences.

Every figure below belongs to the study that gave the treatment.

Wistar rats, a breed used for research, received 2, 12, and 18 milligrams for each kilogram the rats weighed, with belly shots [4]. Treatment started the day after stroke, with four more shots spaced three days apart. Healthy people received 42 to 1260 milligrams once into a vein, with daily treatment following for fourteen days [6]. Mice with inherited muscle disease received 150 micrograms twice a week over six months [5]. The full protein was used in each test. Human work checked safety, while the animal work checked injury and repair.

An amount without those facts can't tell you what helps your injury.

When you see a figure online, ask who received treatment and which substance was given. You also need to know how treatment entered the body and what researchers measured. An amount used to check safety doesn't become a proved treatment amount. Repeating a rat amount online doesn't make that amount suitable for people. Taking a small part from a protein doesn't give that short part all the protein's effects. Human comparison studies haven't found a usual treatment amount for TB-500. Your question remains unanswered because those tests are missing.

What the TB-500 half-life has not shown about clearing it

A TB-500 half-life would tell you how long half of a given amount takes to leave the body. TB-500 has no sound human test of that time. In Phase 1, an early safety study, larger thymosin beta-4 amounts took longer to clear from blood [6]. Blood levels also rose with the amount given. The whole protein weighs 4963 daltons; the small piece weighs 889 daltons. Daltons measure the weight of tiny molecules. The whole protein has a 43-residue chain, meaning forty-three joined protein building blocks. A seven-part piece and that longer chain may take different times to clear.

The whole protein's clearing time can't serve as the small piece's time.

Separate sports drug-testing work looked for TB-500 and its broken-down parts in horses' blood and urine. Researchers developed tests that could find the substance and measure how long detection lasted. Those tests didn't measure the speed at which your body removes the substance. Horse detection tests answer a different question from human safety work. The larger protein has results from a Phase 1 human study. Claims of an exact clearing time for the short piece lack a controlled human test.